KKR & Co. Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bullish +35

KKR & Co. Inc. (NYSE:KKR) Given Consensus Rating of "Moderate Buy" by ...

AI-generated analysis

πŸ“Š KKR & Co. holds a consensus 'Moderate Buy' rating from fourteen analysts with an average one-year target price of $130.50.

πŸ“‰ Recent analyst actions include BMO Capital Markets and Goldman Sachs lowering their price targets, while Barclays raised its target to $124.00.

🏦 Institutional ownership stands at 76.26%, with Brighton Jones LLC increasing its stake by 109.6% in the fourth quarter.

πŸ’° The firm reported Q1 earnings of $1.24 per share on revenue of $5.74 billion with a net margin of 13.94%.

πŸ’΅ KKR declared a quarterly dividend of $0.195, paid on May 29th, offering an annualized yield of 0.8%.

πŸ”„ The board authorized a new share repurchase program permitting the buyback of up to $500 million in shares.

πŸ“ˆ Valuation metrics show a market cap of $90.63 billion and a P/E ratio of 34.33 with a debt-to-equity ratio of 0.70.

πŸ“‰ The stock trades above its 50-day moving average of $95.46 but below its 200-day moving average of $101.54.

Bullish Signals
  • KKR & Co. has received a consensus 'Moderate Buy' rating from fourteen analysts, indicating broad institutional confidence in the stock's outlook.
  • The company recently declared an increased quarterly dividend of $0.195 per share, paid on May 29th, which represents a yield of 0.8% and signals commitment to shareholder returns.
  • KKR's board has authorized a new share repurchase program allowing the buyback of up to $500 million in shares, suggesting management believes the stock is undervalued.
  • Brighton Jones LLC significantly increased its stake by 109.6% in the fourth quarter, adding 2,437 shares to its position valued at $689,000.
  • Arrowstreet Capital Limited Partnership acquired a new stake worth approximately $4.8 million in the second quarter, reflecting continued institutional interest.
Risk Factors
  • BMO Capital Markets decreased its price target on KKR shares from $120.00 to $112.00 while maintaining an 'outperform' rating.
  • Morgan Stanley reduced its price objective from $177.00 to $153.00 in a research note dated April 21st.
  • Goldman Sachs Group lowered its price target on KKR shares from $145.00 to $110.00 in a report issued on April 7th.
  • TD Cowen dropped its target price from $106.00 to $104.00 and set a 'hold' rating for the company in a May 18th report.
  • The stock currently trades below its 200-day simple moving average of $101.54, indicating potential short-term weakness relative to longer-term trends.
Full Analysis
KKR & Co. Inc. (NYSE:KKR) has received a consensus 'Moderate Buy' rating from fourteen analysts covering the stock, with ten issuing buy recommendations and three holding ratings. The average one-year target price among brokerages is $130.50, though recent analyst actions show mixed sentiment, including BMO Capital Markets lowering its target to $112.00 and Goldman Sachs reducing its objective to $110.00, while Barclays increased its target to $124.00. Institutional ownership remains high at 76.26%, with notable activity from hedge funds in the second and fourth quarters. Brighton Jones LLC significantly increased its stake by 109.6% to own 4,661 shares valued at $689,000, while Arrowstreet Capital Limited Partnership acquired a new position worth approximately $4.8 million. Other investors like Bison Wealth LLC and United Bank also established or expanded their holdings during the reported periods. Financially, KKR reported quarterly earnings of $1.24 per share on revenue of $5.74 billion in the quarter ending February 27th, resulting in a net margin of 13.94% and a return on equity of 5.42%. The company recently declared a quarterly dividend of $0.195 per share, paid on May 29th, representing an annualized yield of 0.8%, which is an increase from the previous quarter's payout. The board has authorized a new share repurchase program allowing KKR to buy up to $500 million in outstanding shares, or 0.5% of its stock, through open market purchases. This authorization signals management's belief that the stock may be undervalued. Key valuation metrics include a market capitalization of $90.63 billion, a P/E ratio of 34.33, and a debt-to-equity ratio of 0.70.